CVAC Message Board Post 10901008 | CureVac N.V.
home / stock / cvac / cvac message board
marlonbrendo
(investorshangout)
Posted on: Jan/06/2023 22:04:06
Source: investorshangout
https://investorshangout.com/post/view?id=6519746
znewcar1: $CVAC 29% v2,7M C8.26 f190,283M H8.30 ml5.63
News, Short Squeeze, Breakout and More Instantly...
-
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinations CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone pa...
-
Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation to create leaner and more agile organization Prioritization of high-value opportunities in oncology and other selected diseases, leveraging proprietary mRNA tec...
-
Phase 2 study to assess updated formulations for improved immune responses of multivalent vaccine candidate against influenza B strain Study initiated following previously reported interim data from Phase 2 Part of combined Phase 1/2 study in seasonal influenza Composition of vaccine ca...